In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Ardelyx Inc (NASDAQ: ARDX) was $5.25 for the day, down -1.13% from the previous closing price of $5.31. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 4.18 million shares were traded. ARDX stock price reached its highest trading level at $5.495 during the session, while it also had its lowest trading level at $5.24.
Ratios:
Our analysis of ARDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.03. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 11, 2024, Downgraded its rating to Neutral and sets its target price to $5.50 from $11 previously.
On July 02, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15 to $7.
On April 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $14.Leerink Partners initiated its Outperform rating on April 05, 2024, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when MICHAEL G. RAAB bought 25,000 shares for $5.38 per share.
Williams Laura A sold 7,366 shares of ARDX for $35,316 on Nov 20 ’24. The Chief Medical Officer now owns 308,745 shares after completing the transaction at $4.79 per share. On Nov 20 ’24, another insider, Rosenbaum David P., who serves as the Chief Development Officer of the company, sold 4,941 shares for $4.79 each. As a result, the insider received 23,690 and left with 297,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1257695232 and an Enterprise Value of 1179578368. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.12 while its Price-to-Book (P/B) ratio in mrq is 7.86. Its current Enterprise Value per Revenue stands at 4.684 whereas that against EBITDA is -18.979.
Stock Price History:
Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $4.06. The 50-Day Moving Average of the stock is -9.78%, while the 200-Day Moving Average is calculated to be -21.29%.
Shares Statistics:
ARDX traded an average of 3.79M shares per day over the past three months and 5922920 shares per day over the past ten days. A total of 232.45M shares are outstanding, with a floating share count of 227.75M. Insiders hold about 3.84% of the company’s shares, while institutions hold 61.11% stake in the company. Shares short for ARDX as of 1730332800 were 24055791 with a Short Ratio of 6.34, compared to 1727654400 on 23053125. Therefore, it implies a Short% of Shares Outstanding of 24055791 and a Short% of Float of 11.540000000000001.
